{"id":960951,"date":"2026-05-11T16:42:05","date_gmt":"2026-05-11T20:42:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/"},"modified":"2026-05-11T16:42:05","modified_gmt":"2026-05-11T20:42:05","slug":"immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/","title":{"rendered":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0"},"content":{"rendered":"
\n

DURHAM, N.C., May 11, 2026 (GLOBE NEWSWIRE) — Immunovant (Nasdaq:\u00a0IMVT<\/strong>) today\u00a0announced\u00a0that it will\u00a0report its\u00a0financial results for the\u00a0fourth\u00a0quarter and fiscal year ended\u00a0March\u00a031, 2026, and provide a business update\u00a0at 8:00 a.m. ET on Wednesday, May 20, 2026.<\/p>\n

To access the\u00a0Roivant (Nasdaq: ROIV)\u00a0conference call by phone, please register online using this registration link<\/u><\/a>. The presentation and webcast details will also be available under \u201cNews & Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar<\/a>. The archived webcast will be available on Immunovant\u2019s website after the conference call.<\/p>\n

\n About\u00a0Immunovant<\/strong>\u00a0<\/p>\n

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For\u00a0additional\u00a0information on the Company, please visit\u202fimmunovant.com<\/a>.\u00a0<\/p>\n

\n Contacts:<\/strong>\u00a0<\/p>\n

\n Investors<\/u>\u00a0<\/p>\n

Keyur Parekh\u00a0<\/p>\n

keyur.parekh@roivant.com\u00a0\u00a0<\/p>\n

\n Media<\/u>\u00a0<\/p>\n

Stephanie Lee\u00a0<\/p>\n

stephanie.lee@roivant.com\u00a0<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

DURHAM, N.C., May 11, 2026 (GLOBE NEWSWIRE) — Immunovant (Nasdaq:\u00a0IMVT) today\u00a0announced\u00a0that it will\u00a0report its\u00a0financial results for the\u00a0fourth\u00a0quarter and fiscal year ended\u00a0March\u00a031, 2026, and provide a business update\u00a0at 8:00 a.m. ET on Wednesday, May 20, 2026. To access the\u00a0Roivant (Nasdaq: ROIV)\u00a0conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under \u201cNews & Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar. The archived webcast will be available on Immunovant\u2019s website after the conference call. About\u00a0Immunovant\u00a0 Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the … <\/p>\n

Continue reading “Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0“<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-960951","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nImmunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., May 11, 2026 (GLOBE NEWSWIRE) — Immunovant (Nasdaq:\u00a0IMVT) today\u00a0announced\u00a0that it will\u00a0report its\u00a0financial results for the\u00a0fourth\u00a0quarter and fiscal year ended\u00a0March\u00a031, 2026, and provide a business update\u00a0at 8:00 a.m. ET on Wednesday, May 20, 2026. To access the\u00a0Roivant (Nasdaq: ROIV)\u00a0conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under \u201cNews & Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar. The archived webcast will be available on Immunovant\u2019s website after the conference call. About\u00a0Immunovant\u00a0 Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the … Continue reading "Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-11T20:42:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzcxOCM3NTk2NDk4IzIxMjU4NDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0\",\"datePublished\":\"2026-05-11T20:42:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/\"},\"wordCount\":190,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNzcxOCM3NTk2NDk4IzIxMjU4NDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/\",\"name\":\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNzcxOCM3NTk2NDk4IzIxMjU4NDQ=\",\"datePublished\":\"2026-05-11T20:42:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNzcxOCM3NTk2NDk4IzIxMjU4NDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNzcxOCM3NTk2NDk4IzIxMjU4NDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/","og_locale":"en_US","og_type":"article","og_title":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0 - Market Newsdesk","og_description":"DURHAM, N.C., May 11, 2026 (GLOBE NEWSWIRE) — Immunovant (Nasdaq:\u00a0IMVT) today\u00a0announced\u00a0that it will\u00a0report its\u00a0financial results for the\u00a0fourth\u00a0quarter and fiscal year ended\u00a0March\u00a031, 2026, and provide a business update\u00a0at 8:00 a.m. ET on Wednesday, May 20, 2026. To access the\u00a0Roivant (Nasdaq: ROIV)\u00a0conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under \u201cNews & Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar. The archived webcast will be available on Immunovant\u2019s website after the conference call. About\u00a0Immunovant\u00a0 Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the … Continue reading \"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-11T20:42:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzcxOCM3NTk2NDk4IzIxMjU4NDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0","datePublished":"2026-05-11T20:42:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/"},"wordCount":190,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzcxOCM3NTk2NDk4IzIxMjU4NDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/","name":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzcxOCM3NTk2NDk4IzIxMjU4NDQ=","datePublished":"2026-05-11T20:42:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzcxOCM3NTk2NDk4IzIxMjU4NDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzcxOCM3NTk2NDk4IzIxMjU4NDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Fourth\u00a0Quarter and Fiscal Year Ended\u00a0March\u00a031, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Wednesday,\u00a0May\u00a020, 2026\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/960951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=960951"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/960951\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=960951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=960951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=960951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}